MRC research identifies potential asthma-related immune cell

The Medical Research Council (MRC) has published findings from a study which has identified an immune cell which could be used as the basis for an asthma treatment.

According to the body, newly-discovered cells in the body known as nuocytes may be responsible for generating the chemical parasite-combating chemical Interleukin 13 (IL-13), an excess of which can trigger reactions in asthma sufferers.

It is thought that further research into the workings of these cells and prevention of excessive Il-13 generation will help to reduce the occurrence of asthma attacks.

The MRC’s Dr Andrew McKenzie, the lead author of the study, called the findings “exciting”, given the rarity of discoveries of new immune cell types.

He added: “My group is now pursuing this goal with the aim of translating our research into new treatments.”

Last month, the MRC published research suggesting that patients in vegetative states may still be able to communicate simple yes and no answers through alteration of their brain patterns.